Alison Galloway

1.3k total citations
13 papers, 914 citations indexed

About

Alison Galloway is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Alison Galloway has authored 13 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 3 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Alison Galloway's work include RNA modifications and cancer (10 papers), RNA Research and Splicing (9 papers) and RNA and protein synthesis mechanisms (4 papers). Alison Galloway is often cited by papers focused on RNA modifications and cancer (10 papers), RNA Research and Splicing (9 papers) and RNA and protein synthesis mechanisms (4 papers). Alison Galloway collaborates with scholars based in United Kingdom, Switzerland and Poland. Alison Galloway's co-authors include Martin Turner, Victoria H. Cowling, Elena Vigorito, Simon Andrews, Daniel J. Hodson, Helena Ahlfors, Sarah E. Bell, Kim De Keersmaecker, H. Robson MacDonald and Gerald Grütz and has published in prestigious journals such as Science, Nucleic Acids Research and The Journal of Experimental Medicine.

In The Last Decade

Alison Galloway

12 papers receiving 904 citations

Peers

Alison Galloway
Sheau-Line Feng United States
Latifa Zekri Germany
Sukhinder K. Sandhu United States
Pavan Kumar P United States
Julia Joung United States
Priya Chatterji United States
Sheau-Line Feng United States
Alison Galloway
Citations per year, relative to Alison Galloway Alison Galloway (= 1×) peers Sheau-Line Feng

Countries citing papers authored by Alison Galloway

Since Specialization
Citations

This map shows the geographic impact of Alison Galloway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Galloway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Galloway more than expected).

Fields of papers citing papers by Alison Galloway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Galloway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Galloway. The network helps show where Alison Galloway may publish in the future.

Co-authorship network of co-authors of Alison Galloway

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Galloway. A scholar is included among the top collaborators of Alison Galloway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Galloway. Alison Galloway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Martinelli, Silvia, Ian Powley, Leah Officer-Jones, et al.. (2024). Mitochondrial double-stranded RNA homeostasis depends on cell-cycle progression. Life Science Alliance. 7(11). e202402764–e202402764.
2.
Knop, Katarzyna, et al.. (2023). RAM is upregulated during T cell activation and is required for RNA cap formation and gene expression. PubMed. 3(1). kyad021–kyad021. 4 indexed citations
3.
Galloway, Alison, Abdelmadjid Atrih, Harunori Yoshikawa, et al.. (2021). Upregulation of RNA cap methyltransferase RNMT drives ribosome biogenesis during T cell activation. Nucleic Acids Research. 49(12). 6722–6738. 49 indexed citations
4.
Galloway, Alison, Abdelmadjid Atrih, Renata Grzela, et al.. (2020). CAP-MAP: cap analysis protocol with minimal analyte processing, a rapid and sensitive approach to analysing mRNA cap structures. Open Biology. 10(2). 190306–190306. 38 indexed citations
5.
Iñesta-Vaquera, Francisco, Viduth K. Chaugule, Alison Galloway, et al.. (2018). DHX15 regulates CMTR1-dependent gene expression and cell proliferation. Life Science Alliance. 1(3). e201800092–e201800092. 34 indexed citations
6.
Galloway, Alison & Victoria H. Cowling. (2018). mRNA cap regulation in mammalian cell function and fate. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1862(3). 270–279. 158 indexed citations
7.
Ahlfors, Helena, Alexander Saveliev, Alison Galloway, et al.. (2017). Maintenance of the marginal-zone B cell compartment specifically requires the RNA-binding protein ZFP36L1. Nature Immunology. 18(6). 683–693. 47 indexed citations
8.
Galloway, Alison & Martin Turner. (2017). Cell cycle RNA regulons coordinating early lymphocyte development. Wiley Interdisciplinary Reviews - RNA. 8(5). 28 indexed citations
9.
Galloway, Alison, et al.. (2016). The RNA-Binding Proteins Zfp36l1 and Zfp36l2 Enforce the Thymic β-Selection Checkpoint by Limiting DNA Damage Response Signaling and Cell Cycle Progression. The Journal of Immunology. 197(7). 2673–2685. 54 indexed citations
10.
Galloway, Alison, Alexander Saveliev, Sebastian Łukasiak, et al.. (2016). RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence. Science. 352(6284). 453–459. 123 indexed citations
11.
Turner, Martin, Alison Galloway, & Elena Vigorito. (2014). Noncoding RNA and its associated proteins as regulatory elements of the immune system. Nature Immunology. 15(6). 484–491. 153 indexed citations
12.
Lu, Dong, Rinako Nakagawa, Sandra Lazzaro, et al.. (2014). The miR-155–PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation. The Journal of Experimental Medicine. 211(11). 2183–2198. 70 indexed citations
13.
Hodson, Daniel J., Michelle L. Janas, Alison Galloway, et al.. (2010). Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia. Nature Immunology. 11(8). 717–724. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026